We observed lower mutation frequencies in PIK3CA in our IBC cohort than previous ones, which may be due to sampling bias arising from the small sample size, as PIK3CA was more frequently mutated in hormone receptor-positive (HR+) cancers, and our study had a lower fraction of HR+ cases [51]. The gene discussed is PIK3CA; the disease is cancer.